相关实验视频
Updated: Jul 16, 2026
10:30
Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
Published on: January 25, 2017
9.2K
基因改造的乳酸细菌的构建,产生抗干乐素-31受体 A 单链可变片段
Aito Murakami1, Hotaru Ikeda1, Masahiro Yoda2
1Institute for Aqua Regeneration, Shinshu University, Nagano, 399-4598, Japan.
Molecular biology reports
|November 14, 2025
概括
研究人员开发了一种新型的乳酸细菌系统,以传递介素-31受体α (IL-31Ra) 单链可变片段 (scFv). 这种系统的灵感来自于nemolizumab,通过抑制IL-31信号传递,显示出治疗呼吸系统疾病的潜力.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 尼莫利祖马布 (Nemolizumab) 是一种IL-31R抗剂,已被批准用于治疗亚托皮炎.
- 洲际蛋白-31 (IL-31) 涉及皮肤炎症和呼吸系统疾病.
- 目前用于IL-31R疗法的抗体输送方法是不理想的.
研究的目的:
- 为IL-31Ra单链可变片段 (scFv) 建立一个新的本地传递系统.
- 利用复合乳酸细菌 (gmLAB) 加强尼莫利祖马布在呼吸系统疾病中的应用.
主要方法:
- 通过电穿孔制造的转基因乳酸细菌 (gmLAB).
- 确认使用西式涂抹和尼依赖的复合scFv生产.
- 通过ELISA验证了scFv与人类IL-31Ra的结合,并在体外评估了STAT3酸化抑制.
主要成果:
- gmLAB成功地产生了功能IL-31Ra scFv.
- 再组合scFv与人类IL-31Ra特别结合.
- 实验室试验证明了IL-31诱导的STAT3酸化的抑制.
结论:
- 成功开发了一种基于尼莫利祖马布的新型gmLAB工具来表达IL-31Ra scFv.
- 在gmLAB系统显示潜力作为一个有效的交付方法IL-31Ra scFv.
- 这种方法可能为肺部和呼吸道疾病提供新的治疗策略.
相关概念视频
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...